Six-year retrospective review of drug reaction with eosinophilia and systemic symptoms

Acta Dermato-Venereologica

Volumn 92, Issue 2, 2012, Pages 200-205

  Wongkitisophon, Pranee ^a   Chanprapaph, Kumutnart ^a   Rattanakaemakorn, Ploysyne ^a   Vachiramon, Vasanop ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Adverse drug reaction; Drug hypersensitivity; Drug reaction with eosinophilia and systemic symptoms

Indexed keywords

ALLOPURINOL; AMLODIPINE; ATENOLOL; AZATHIOPRINE; CELECOXIB; CHINESE DRUG; CORTICOSTEROID; DAPSONE; DILTIAZEM; ENALAPRIL; ERLOTINIB; ETHAMBUTOL; GLIPIZIDE; HYDROXYCHLOROQUINE; IBUPROFEN; ISONIAZID; LACTULOSE; LAMIVUDINE; LOSARTAN; METHOTREXATE; NEVIRAPINE; PHENYTOIN; PREDNISOLONE; PYRAZINAMIDE; RIFAMPICIN; ROSUVASTATIN; SALAZOSULFAPYRIDINE; SIMVASTATIN; TORASEMIDE; ZIDOVUDINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRESS SYNDROME; DRUG WITHDRAWAL; EOSINOPHILIA; ERYTHRODERMA; FEMALE; FEVER; HEPATITIS; HUMAN; LATENT PERIOD; LYMPHADENOPATHY; LYMPHOCYTOPENIA; LYMPHOCYTOSIS; MALE; NEPHRITIS; PNEUMONIA; PRIORITY JOURNAL; PUSTULE; RASH; RETROSPECTIVE STUDY; STEROID THERAPY; TERTIARY HEALTH CARE; THAILAND; THROMBOCYTOPENIA; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; ALLOPURINOL; ANTI-HIV AGENTS; ANTI-INFLAMMATORY AGENTS; ANTICONVULSANTS; DEXAMETHASONE; DRUG ERUPTIONS; EDEMA; ENZYME INHIBITORS; EOSINOPHILIA; FACE; FEMALE; FEVER; HUMANS; LIVER; MALE; MIDDLE AGED; NEVIRAPINE; PHENYTOIN; PREDNISOLONE; PRURITUS; RECURRENCE; RETROSPECTIVE STUDIES; THAILAND; TIME FACTORS; WITHHOLDING TREATMENT; YOUNG ADULT;

EID: 84859573423     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-1222     Document Type: Article

References (22)

1. Bocquet H, Bagot M, Roujeau J. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms). Semin Cutan Med Surg 1996; 15: 250-257.
2. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994; 331: 1272-1285.
3. Begon E, Roujeau JC. Syndrome d'hypersensibilité médicamenteuse ou DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms). Ann Dermatol Venereol 2004; 131: 293-297.
4. Suzuki Y, Inagi R, Aono T, Yamanishi K, Shiohara T. Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome. Arch Dermatol 1998; 134: 1108-1112.
5. Tohyama M, Yahata Y, Yasukawa M, Inagi R, Urano Y, Yamanishi K, et al. Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6. Arch Dermatol 1998; 134: 1113-1117.
6. Descamps V, Collot S, Mahe E, Houhou N, Crickx B, Ranger-Rogez S. Active human herpesvirus 6 infection in a patient with drug rash with eosinophilia and systemic symptoms. J Invest Dermatol 2003; 121: 215-216.
7. Shiohara T, Iijima M, Ikezawa Z, Hashimoto K. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br J Dermatol 2007; 156: 1083-1084.
8. Shiohara T, Inaoka M, Kano Y. Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses. Allergol Int 2006; 55: 1-8.
9. Prussick R, Shear NH. Dapsone hypersensitivity syndrome. J Am Acad Dermatol 1996; 35: 346-349.
10. Kardaun SH, Sidoroff A, Valeyrie-Allanore L, Halevy S, Davidovici BB, Mockenhaupt M, et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol 2007; 156: 609-611.
11. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-245.
12. Schlienger RG, Shear NH. Antiepileptic drug hypersensitivity syndrome. Epilepsia 1998; 39: S3-S7.
13. Shear NH, Spielberg SP. Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. J Clin Invest 1988; 82: 1826-1832.
14. Chiou CC, Yang LC, Hung SI, Chang YC, Kuo TT, Ho HC, et al. Clinicopathological features and prognosis of drug rash with eosinophilia and systemic symptoms: a study of 30 cases in Taiwan. J Eur Acad Dermatol Venereol 2008; 22: 1044-1049.
15. Kaniwa N, Saito Y, Aihara M, Matsunaga K, Tohkin M, Kuraose K, et al. HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Steven-Johnson syndrome and toxic epidermal necrolysis. Pharmacogenomic 2008; 9: 1617-1622.
16. Hung SI, Chung WH, Liou LB, Chu CC, Lin M, Huang HP, et al. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci USA 2005; 102: 4134-4139.
17. Martin AM, Nolan D, James I, Cameron P, Keller J, Moore C, et al. Predisposition to nevirapine hypersensitivity associated with HLA-DRB1*0101 and abrogated by low CD4 T cell counts. AIDS 2005; 19: 97-99.
18. Shear NH, Spielberg SP, Grant DM, Tang BK, Kalow W. Differences in metabolism of sulphonamides predisposing to idiosyncratic toxicity. Ann Intern Med 1986; 105: 179-184.
19. Aihara Y, Ito SI, Kobayashi Y, Yamakawa Y, Aihara M, Yokota S. Carbamazepine-induced hypersensitivity syndrome associated with transient hypogammaglobulinaemia and reactivation of human herpesvirus 6 infection demonstrated by real-time quantitative polymerase chain reaction. Br J Dermatol 2003; 149: 165-169.
20. Choquet-Kastylevsky G, Intrator L, Chenal C, Bocquet H, Revuz J, Roujeau JC. Increased levels of interleukin 5 are associated with the generation of eosinophilia in druginduced hypersensitivity syndrome. Br J Dermatol 1998; 139: 1026-1032.
21. Eshki M, Allanore L, Musette P, Milpied B, Grange A, Guillaume JC, et al. Twelve year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms. Arch Dermatol 2009; 145: 67-72.
22. Zuliani E, Zwahlen H, Gilliet F, Marone C. Vancomycininduced hypersensitivity reaction with acute renal failure: resolution following cyclosporine treatment. Clin Nephrol 2005; 64: 155-158.